Home
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
Health News
FDA Drug Safety Communication: Reclast
The U.S. Food and Drug Administration (FDA) has approved an update to the drug label for Reclast ( zoledronic acid) to better inform healthcare professionals and patients of the risk of kidney (renal) failure.
REFINE
medications
Reclast (1)
Apply Reclast filter
conditions
(-)
Remove Kidney Disease filter
Kidney Disease
(-)
Remove Kidney Failure filter
Kidney Failure
(-)
Remove Neuromuscular Disease filter
Neuromuscular Disease
Osteoporosis (1)
Apply Osteoporosis filter
(-)
Remove Patient Safety Education filter
Patient Safety Education